or Try an Advanced Search...

    Regeneron Stocks List

    Symbol Grade Name % Change
    ADVM F Adverum Biotechnologies, Inc. 4.30
    SNY C Sanofi -0.91
    REGN B Regeneron Pharmaceuticals, Inc. 2.07
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Colorectal Cancer Macular Degeneration Pain Adverum Biotechnologies Angiogenesis Animal Health Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cac 40 Cancer Cardiovascular Disease Cartilage Cholesterol Chronic Kidney Disease Clinical Development

    Related ETFs - A few ETFs which own one or more of the above listed Regeneron stocks.

    Symbol Grade Name Weight
    IBBQ C Invesco Nasdaq Biotechnology ETF 9.39
    IBB C iShares Nasdaq Biotechnology Index Fund 8.14
    VIRS C Pacer BioThreat Strategy ETF 7.77
    BBH B Market Vectors Biotech ETF 7.72
    BIB C ProShares Ultra Nasdaq Biotechnology 6.68
    View all Regeneron ETFs...
    Compare ETFs
    Compare IBB to BBH Compare IBB to BIB Compare VIRS to BIB

        Regeneron Stocks Recent News

        Date Stock Title
        May 5 REGN Wall Street Breakfast: The Week Ahead
        May 3 SNY Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
        May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
        May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
        May 3 ADVM Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
        May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
        May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
        May 3 SNY Q1 2024 Kymera Therapeutics Inc Earnings Call
        May 2 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript
        May 2 ADVM Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 SNY Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
        May 2 REGN Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
        May 2 REGN Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
        May 2 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
        May 2 REGN Regeneron Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 REGN Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
        May 2 REGN Regeneron falls after Q1 miss; announces $3B share buybacks
        May 2 REGN 3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
        May 2 SNY 3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
        May 2 REGN Regeneron Earnings Miss; Biotech Giant's Stock Falls
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Colorectal Cancer Macular Degeneration Pain Adverum Biotechnologies Angiogenesis Animal Health Antibodies Asthma Atopic Dermatitis Biopharmaceutical Biotechnology Bone Breakthrough Therapy Cac 40 Cancer Cardiovascular Disease Cartilage Cholesterol Chronic Kidney Disease Clinical Development
        Regeneron

        Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.

        More about Regeneron
        Browse All Tags